Nuphase Clinical Research Inc is categorized under Commercial Research Laboratory in Miami, FL and active since 2009.
Nuphase Clinical Research Inc was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Research Laboratory business, which does work in the B2B market, and is classified as a Commercial Research Laboratory, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Daniel Nadal at the company’s single location by writing to 3500 Coral Way # 102, Miami, Florida FL 33145 or by phoning (305) 668-7181. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Nuphase Clinical Research Inc |
| Contact Person: | Daniel Nadal |
| Address: | 3500 Coral Way # 102, Miami, Florida 33145 |
| Phone Number: | (305) 668-7181 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Research Laboratory |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Nuphase Clinical Research Inc was started in 2009 to provide professional Commercial Research Laboratory under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Daniel Nadal for inquiries that concern Nuphase Clinical Research Inc by calling the company number (305) 668-7181, as your correspondence is most welcome. Additionally, the physical location of the single location of Nuphase Clinical Research Inc can be found at the coordinates 25.749772,-80.250879 as well as the street address 3500 Coral Way # 102 in Miami, Florida 33145.
For its online presence, you may visit Nuphase Clinical Research Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.